| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8440748 | European Journal of Cancer | 2016 | 11 Pages |
Abstract
This is the first study to provide survival data in OPSCC stratified by cell-mediated immune response to HPV16 peptides. Within the HPV16+ OPSCC cohort, enhanced immunoreactivity to antigen E7 was linked to improved survival. An increase in regulatory T cell frequencies after treatment may suggest that immunosuppression can contribute to a reduced HPV-specific cell-mediated response.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Liam Masterson, Matt Lechner, Sarah Loewenbein, Hassan Mohammed, Cameron Davies-Husband, Tim Fenton, Holger Sudhoff, Piyush Jani, Peter Goon, Jane Sterling,